Overview
- Primary care teams and patient groups are running free glucose checks, FINDRISC risk testing and education events from Nov. 13–15 across Spain and Latin America.
- Castilla-La Mancha confirmed a four‑year, €147 million platform launching in early 2026 to monitor chronic patients at home, starting with people living with diabetes.
- Galician advocates urged Sergas to secure teplizumab for delaying type 1 onset through compassionate use, citing U.S. authorization and ongoing European consideration.
- Specialists report large undiagnosed populations and rising type 2 in children and adolescents linked to obesity, poor diet and sedentary behavior.
- Awareness actions include Valladolid street screenings and Rome’s Tor Vergata illuminating its Rectorate with the blue circle logo from Nov. 10–18.